Advances in Liposomal Drug Delivery Systems
American Journal Of Pharmacy And Pharmacology · 28.02.2025 · 6 (1) · 17-29
DOI: 10.71465/ajpp.3368 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal Of Pharmacy And Pharmacology, online erschienen am 28.02.2025. Verfasst von Dr. Lucia Fernandez,. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Liposomal drug delivery systems (LDDS) have revolutionized pharmaceutical therapy by enhancing the therapeutic index of drugs through improved pharmacokinetics and targeted delivery. These nanocarriers offer a biocompatible, versatile platform to encapsulate a wide range of bioactive compounds, reducing toxicity and improving bioavailability. Advances in liposomal formulation, including PEGylation, ligand targeting, and stimuli-responsive systems, have further expanded their clinical utility. This review provides a comprehensive overview of modern liposomal technologies and their implications in drug delivery.
Zitieren
APA
Fernandez,, D. L. (2025). Advances in Liposomal Drug Delivery Systems. American Journal Of Pharmacy And Pharmacology, 6(1), 17-29. https://doi.org/10.71465/ajpp.3368
Vancouver
Fernandez, DL. Advances in Liposomal Drug Delivery Systems. American Journal Of Pharmacy And Pharmacology. 2025;6(1):17-29. doi:10.71465/ajpp.3368
BibTeX
@article{Fernandez2025,
author = {Fernandez,, Dr. Lucia},
title = {Advances in Liposomal Drug Delivery Systems},
journal = {American Journal Of Pharmacy And Pharmacology},
year = {2025},
volume = {6},
number = {1},
pages = {17--29},
doi = {10.71465/ajpp.3368}
}
EUVIMED